Detalhe da pesquisa
1.
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598658
2.
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
N Engl J Med
; 385(16): 1485-1495, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644472
3.
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
N Engl J Med
; 385(24): 2241-2251, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379915
4.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med
; 385(19): 1774-1785, 2021 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551225
5.
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med
; 384(5): 403-416, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378609
6.
No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial.
Clin Infect Dis
; 77(9): 1238-1246, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335963
7.
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
Clin Infect Dis
; 77(12): 1635-1643, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435958
8.
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
N Engl J Med
; 383(25): 2427-2438, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991794
9.
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial.
J Infect Dis
; 226(10): 1731-1742, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35535503
10.
Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays.
J Clin Microbiol
; 58(9)2020 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32493784
11.
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge.
N Engl J Med
; 385(26): 2485-2487, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731553
12.
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
N Engl J Med
; 384(23): 2259-2261, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822494
13.
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med
; 384(1): 80-82, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270381
14.
Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
PLoS Pathog
; 8(8): e1002895, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952447
15.
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial.
Hum Vaccin Immunother
; 20(1): 2327736, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513689
16.
Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.
Infect Immun
; 81(11): 3992-4000, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23940209
17.
Treatment with monoclonal antibodies against Clostridium difficile toxins.
N Engl J Med
; 362(3): 197-205, 2010 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20089970
18.
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials.
Lancet Infect Dis
; 23(5): 621-633, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682364
19.
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients.
Cancer Commun (Lond)
; 43(7): 749-764, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377402
20.
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial.
Int J Infect Dis
; 137: 28-39, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820782